Breast cancer immunotherapy represents a groundbreaking advancement in oncology, encompassing various innovative approaches to cancer treatment. German clinics are at the forefront of implementing these advanced therapies, from immune checkpoint inhibitors to dendritic cell vaccines – the latter made possible by Ralph Steinman... 

Dendritic cell breast cancer treatment is a breakthrough immunotherapy approach that activates the patient's anti-cancer immunity through personalized vaccination. This innovative method improves treatment outcomes by 15-20% across different clinical situations: after tumor removal surgery, with lymph node involvement, in metastatic disease,...

A soft tissue sarcoma is a malignant, non-epithelial tumor. Such tumors may arise from muscles, adipose tissue, cartilage tissue, blood vessels, skin, etc. Sarcomas differ from cancer in that they do not grow from the epithelium. These are relatively rare tumors. They can develop in any part of the body. 

Glioblastoma is a malignant neoplasm that arises from glial cells of the brain. The tumor is heterogeneous and requires a differentiated therapeutic approach. When elaborating a treatment regimen, German oncologists take into account the molecular and genetic composition of the tumor and its location in relation to vital parts of the brain.

Standard therapy for glioblastoma includes surgical removal of the tumor in combination with chemotherapy or radiation therapy. Supplementing the standard protocol with the dendritic cells vaccine is the most promising approach, the effectiveness of which exceeds all therapies that are currently used in neurooncology.

Cancer is one of the most common causes of human deaths, along with cardiovascular pathologies. A complete cure or effective treatment has not been developed yet. Moreover, traditional therapy may not bring results to its advanced stage, so patients simply receive symptomatic treatment.

Immunotherapy represents a groundbreaking approach to cancer treatment, with dendritic cell therapy emerging as one of its most promising innovations. This revolutionary method harnesses the power of the patient's own immune system to fight malignant tumors. The significance of dendritic cells in cancer treatment was recognized with...

Dendritic cell prostate cancer treatment represents a groundbreaking immunotherapy approach, recognized by the 2011 Nobel Prize in Medicine awarded to Ralph Steinman. This innovative method can be prescribed to men of all ages and at any stage of prostate cancer, serving as an effective addition to standard treatment protocols.